Ortec animal study shows fibrin microbeads allow for high recovery of stem cells

By Elaine Rigoli

Tampa, Fla., May 16 - Ortec International, Inc. announced Tuesday that an article, entitled "High yield isolation expansion and differentiation of rat bone-marrow-derived mesenchymal stem cells with fibrin microbeads," will appear in the August edition of the peer-reviewed journal, Tissue Engineering.

The article describes results of experiments in a rat model demonstrating that Ortec's fibrin microbeads technology increases by nearly fourfold the yield of mesenchymal stem cells recovered from bone marrow.

New York-based Ortec develops stem-cell technology and biomaterials.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.